AI & GxP Journal
About the Journal
The Journal of AI & GxP is a peer-reviewed publication focused on how digital and predictive technologies are transforming GxP-regulated industries. The journal aims to bridge the gap between innovation and compliance—helping life science professionals apply new tools responsibly and effectively.
It offers a platform for quality, manufacturing, regulatory, and IT professionals to share insights, success stories, and lessons learned from implementing digital transformation, automation, data analytics, and artificial intelligence (AI) within pharmaceutical and biotechnology operations. By connecting real-world applications with compliance principles, the Journal of AI & GxP promotes practical, science-based approaches that improve data integrity, streamline operations, and support, patient safety.
Call for Papers
The Journal of AI & GxP invites professionals, researchers, and industry experts to share their insights and experiences on how digital and predictive technologies are shaping GxP-regulated environments. We welcome submissions that highlight real-world applications, best practices, lessons learned, and forward-looking ideas that connect innovation with compliance.
Topics of interest include:
- Digital transformation in GMP, GLP, and GCP operations
- Predictive analytics and data-driven decision-making
- Automation, cloud systems, and advanced process control
- Validation and lifecycle management of digital tools and platforms
- Data integrity and governance in a digital environment
- Case studies on AI technology implementation and compliance outcomes
- Regulatory perspectives on emerging technologies such as AI/ML
Submission details:
- Article types: Original papers, reviews, or case studies
- Length: 1,000–1,200 words
- Frequency: Rolling submissions accepted year-round
- Contact: info@kenx.org
- Submission Form: (Click here)
Meet Our Editor-In-Chief
Kim Huynh-Ba, MS
Managing Director, Pharmalytik LLC
Adjunct Professor, RAQA, Temple University School of Pharmacy
Adjunct Professor, Department of Chemistry, Illinois Institute of Technology
Former Council of Experts, USP
Fellow, AAPS
Kim Huynh-Ba is the Managing Director of Pharmalytik, LLC, a consulting and training organization. She has over 30-years of experience in Validation, Audits, Data Integrity, Quality Systems, CMC, Analytical Lifecycle, and Stability Sciences. She is a Council of Experts of US Pharmacopeia (2015-2025), where she chairs the Small Molecules IV Expert Committee. She is also a member of the USP Drug-Device Combination Products Sub-Committee. Kim is a former President and Distinguished Board Member of the Eastern Analytical Symposium (EAS). She is chairing the American Association of Pharmaceutical Scientists (AAPS) career committee and was named Fellow since 2020. Kim has served on various editorial boards such as AAPS Open and Pharmaceutical Chemistry Journal. Her extensive experience and involvement in various aspects of the pharmaceutical industry highlights her commitment to advance quality standards and best practices in the field.
Kim is an Adjunct Professor at Temple University-School of Pharmacy and Illinois Institute of Technology (IIT), where she teaches GMPs, Quality Audit, ICH quality guidelines, and Pharmaceutical Analysis for their Regulatory Quality and Compliance Programs. She has authored close to fifty articles and is the editor of several book volumes, “Handbook of Stability Testing of Pharmaceutical products,” “Stability Testing to Support Global Markets,” and the textbook “Analytical Testing for the Pharmaceutical GMP laboratories.” Overall, Kim’s multifaceted roles reflect a strong dedication to education, quality, and compliance within the pharmaceutical industry.